Ajinomoto Biopharma Services
Ajinomoto Bio-Pharma Services is a global CDMO offering cutting-edge bioconjugation platform consists of site-specific conjugation technology and novel linker. We have developed an innovative conjugation method based on proprietary Fc-affinity peptides that provides significant advantages for next generation TPDs; 1) enhanced therapeutic window with precise DAR control and highly-stable linker platform; 2) straightforward and cost-effective conjugate process, requiring no genetic modification or enzymes; and 3) dual-payload and other flexible drug designs including DAR-1.
